Koichi Hagiwara

发表

Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4

A. Okamoto, D. Demetrick, M. Serrano, 1996, Molecular carcinogenesis.

Molecular analysis of the cyclin‐dependent kinase inhibitor genes p15INK4b/MTS21, p16INK4/MTS1, p18 and pl9 in human cancer cell lines

A. Okamoto, Y. Xiong, S. Hussain, 1996, International journal of cancer.

Purification of a cell growth factor from a human lung cancer cell line: Its relationship with ferritin

T. Okabe, M. Fujisawa, Yoshio Yazaki, 1994, Journal of Cellular Physiology.

Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles.

C. Harris, D. Ryberg, A. Haugen, 1997, Carcinogenesis.

Mutations and altered expression of p16INK4 in human cancer.

A. Okamoto, D. Demetrick, M. Serrano, 1994, Proceedings of the National Academy of Sciences of the United States of America.

[Primary pulmonary lymphoma diagnosed by transbronchial biopsy and bronchoalveolar lavage findings].

N. Keicho, F. Takaku, T. Oka, 1990, Nihon Kyobu Shikkan Gakkai zasshi.

Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene

K. Miyazono, C. Heldin, K. Hagiwara, 1991, Molecular and cellular biology.

Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β

Mohammed A. Khan, M. A. Khan, W. Bennett, 1997, Oncogene.

A novel putative tyrosine kinase receptor encoded by the eph gene.

H. Hirai, K. Hagiwara, F. Takaku, 1987, Science.

FHIT mutations in human primary gastric cancer.

C. Harris, Mohammed A. Khan, M. A. Khan, 1997, Cancer research.

Frequent mutations in the p53 gene in human myeloid leukemia cell lines.

Koichi Sugimoto, Y. Yazaki, K. Miyagawa, 1992, Blood.

Mutations of the p53 gene in lymphoid leukemia.

Koichi Sugimoto, K. Miyagawa, K. Sugimoto, 1991, Blood.

COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis.

V. Rotter, C. Harris, X. W. Wang, 1999, Cancer research.

Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.

C. Harris, K. Hagiwara, M. McMenamin, 1999, Cancer research.

Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells.

K. Hagiwara, F. Takaku, T. Okabe, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo.

Y. Yazaki, H. Hirai, H. Kozutsumi, 1994, Oncogene.

Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.

H. Kuwano, H. Osawa, H. Shoji, 2000, International journal of oncology.